drugset / Trial / NCT06388551
A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase 1，randomized, double-blind, placebo-controlled, SAD study to evaluate the safety, tolerability and pharmacokinetics of oral LPM526000133 Fumarate Capsules (LY03017) in healthy adult subjects.
Timeline
- Start
- 2024-05-10
- Primary completion
- 2025-03-30
- Completion
- 2025-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY03017 | Unknown | — | Oral |
Indications
No indication recorded.